All News about Corcept Therapeutics![]() ![]() Via Benzinga
![]() ![]()
Analyst Ratings for Corcept Therapeutics
April 04, 2023
Via Benzinga
![]()
Analyst Expectations for Corcept Therapeutics's Future
March 08, 2023
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]()
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
Via GlobeNewswire
![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Corcept Therapeutics Provides Miricorilant Clinical Development Update
December 08, 2022
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
August 01, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|